Charles River Laboratories | CRL - Ebit



Charles River Laboratories reported $132.33M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Agilent USD 394M 31M Jul/2025
Align Technology USD 163.03M 23.69M Jun/2025
Bio-Rad Laboratories USD 426.6M 363.6M Jun/2025
Bruker USD 11.9M 89.8M Jun/2025
Cardinal Health USD 629M 178M Jun/2025
Charles River Laboratories USD 132.33M 55.89M Jun/2025
Cigna USD 2.36B 348M Jun/2025
CVS Health USD 2.41B 2.17B Jun/2025
Danaher USD 760M 939M Jun/2025
Dentsply International USD 111M 23M Jun/2025
Elevance Health USD 2.63B 508M Jun/2025
Galapagos EUR -57027000 101.68M Jun/2025
Hologic USD 263.9M 37.7M Jun/2025
Humana USD 1.1B 753M Jun/2025
Illumina USD 331M 119M Jun/2025
Incyte USD 310.82M 27.18M Jun/2025
IQVIA Holdings USD 556M 187M Jun/2025
Laboratory Of America USD 462.8M 6.2M Jun/2025
Lonza CHF 727M 193M Dec/2024
McKesson USD 1.08B 476M Jun/2025
Merck EUR 1.03B 26M Jun/2025
Mettler Toledo International USD 265.44M 28.7M Jun/2025
Novartis USD -9190000000 13.87B Jun/2025
Pfizer USD 2.6B 3.33B Jun/2025
Quest Diagnostics USD 438M 32M Jun/2025
Revvity USD 90.76M 79.15M Jun/2025
Thermo Fisher Scientific USD 1.92B 353M Jun/2025
United Therapeutics USD 276.9M 105.9M Jun/2025
UnitedHealth USD 5.15B 4.39B Jun/2025
Waters USD 188.21M 19.32M Jun/2025
West Pharmaceutical Services USD 153.7M 28.7M Jun/2025